BMS-Tempus, Roche-Zymeworks, and LGM-Sannova deals show what AI data, trispecifics, and nitrosamine testing mean for CMC, QA, and development teams.
|Articles|February 1, 2022
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe, BioPharma Outsourcing Innovation, February 2022
Pharmaceutical Technology Europe, BioPharma Outsourcing Innovation, February 2022
Author(s)Pharmaceutical Technology Editors
Pharmaceutical Technology Europe's BioPharma Outsourcing Innovation supplement examines outsourcing development services, spray draying, capacity challenges, and more.
Advertisement
Throughout a tumultuous 2021, the pharmaceutical industry has seen continual innovations in operations, technology, and practices in the outsourcing sector.
Pharmaceutical Technology Europe's BioPharma Outsourcing Innovation supplement examines outsourcing development services, spray draying, capacity challenges, and more.
Articles in this issue
over 4 years ago
The Next Frontier in Pharmaceutical OutsourcingAdvertisement
Related to this article
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Nitrosamine Problems and Industry Solutions: PharmTech Explained
2
OpenAI Bets on Accelerating Drug Development Timelines With Orchestra Bio
3
Ask the Expert: Choosing Ingredient Suppliers
4
AAPS PharmSci 360 2026: E&L Standards Harmonization
5